Several high-profile cases have highlighted the impact of financial conflicts in epidemiology. For instance, the controversy surrounding the tobacco industry's funding of research to downplay the health risks of smoking, or the pharmaceutical industry's role in the opioid crisis, underscore the potential for financial interests to distort scientific findings.
